Overview Financials News + Filings Key Docs Charts Ownership Insiders |
QUAKER CHEMICAL CORP (KWR)
|
Add to portfolio |
|
|
Price: |
$239.73
| | Metrics |
OS: |
17.9
|
M
| |
|
|
Market cap: |
$4.3
|
B
| |
|
|
Net debt:
|
$772
|
M
| |
|
|
EV:
|
$5.07
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 1.3 | 1.4 | 1.0 | 1.0 | 0.9 | 0.9 | 746.7 | 737.6 |
Revenue growth | -7.2% | 36.8% | -3.5% | 20.1% | 0.1% | -99.9% | 1.2% | -3.7% |
Cost of goods sold | 1,330.9 | 1,166.5 | 904.2 | 741.4 | 555.2 | 528.6 | 466.6 | 459.8 |
Gross profit | -1,329.7 | -1,165.2 | -903.2 | -740.4 | -554.3 | -527.7 | 280.1 | 277.7 |
Gross margin | -104863.0% | -85234.2% | -90413.9% | -71531.5% | -64309.0% | -61292.2% | 37.5% | 37.7% |
Selling, general and administrative | 455.4 | 418.9 | 380.8 | 283.8 | 207.9 | 198.8 | 193.7 | 196.4 |
EBITA | 159.2 | 185.2 | 140.0 | 113.4 | 106.2 | 96.0 | 92.4 | 88.4 |
EBITA margin | 12556.1% | 13545.2% | 14018.3% | 10952.0% | 12320.8% | 11146.0% | 12.4% | 12.0% |
Amortization of intangibles | | | | | | | 7.0 | 6.8 |
EBIT | 159.2 | 185.2 | 140.0 | 113.4 | 106.2 | 96.0 | 85.4 | 81.6 |
EBIT margin | 12556.1% | 13545.2% | 14018.3% | 10952.0% | 12320.8% | 11146.0% | 11.4% | 11.1% |
Pre-tax income | 7.1 | 147.0 | 27.1 | 28.9 | 83.1 | 60.7 | 63.0 | 70.2 |
Income taxes | 24.9 | 34.9 | -5.3 | 2.1 | 25.1 | 41.7 | 0.0 | 17.8 |
Tax rate | 350.2% | 23.8% | | 7.2% | 30.1% | 68.7% | 0.0% | 25.3% |
Net income | -15.9 | 121.4 | 39.7 | 31.6 | 59.5 | 20.3 | 61.4 | 51.2 |
Net margin | -1256.4% | 8878.5% | 3969.8% | 3055.3% | 6899.4% | 2355.2% | 8.2% | 6.9% |
|
Diluted EPS | ($0.89) | $6.80 | $2.23 | $2.09 | $4.47 | $1.53 | | $3.87 |
Shares outstanding (diluted) | 17.9 | 17.9 | 17.8 | 15.2 | 13.3 | 13.2 | | 13.2 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|